Injektionsanästhesie beim Pferd – Was gibt es Neues?

Bereits vor der Einführung der Inhalationsanästhesie in die Pferdeanästhesie spielte die Injektionsanästhesie in Form der Chloralhydrat- und Pentobarbitalnarkose eine große Rolle. Diese Anästhesieformen waren jedoch schlecht steuerbar, mit einem hohen Narkoserisiko verbunden und enthielten keine antinozizeptive Komponente. Das Interesse an der Injektionsanästhesie hat sich aufgrund des Konzepts der balancierten Anästhesie (Analgesie, Hypnose, Muskelrelaxierung durch die Kombination verschiedener Medikamente) und vor allem der potenziell geringeren Mortalitätsraten im Vergleich zur Inhalationsanästhesie beim Pferd, erneuert und zur Entwicklung neuer und sicherer Protokolle geführt.

Literatur

• 1 Bettschart-Wolfensberger R, Bowen I, Freeman S, Weller R, Clarke K. Medetomidine-ketamine anaesthesia induction followed by medetomidine-propofol in ponies: infusion rates and cardiopulmonary side effects.  Equine Vet J. 2003;  35 308-313
• 2 Bettschart-Wolfensberger R, Taylor P, Sear J, Bloomfield M, Rentsch K, Dawling S. Physiologic effects of anesthesia induced and maintained by intravenous administration of a climazolam-ketamine combination in ponies premedicated with acepromazine and xylazine.  Am J Vet Res. 1996;  57 1472-1477
• 3 Bidwell L, Bramlage L, Rood W. Equine perioperative fatalities associated with general anaesthesia at a private practice – a retrospective case series.  Vet Anaesth Analg. 2007;  34 23-30
• 4 Boscan P, Rezende M, Grimsrud K, Stanley S, Mama K, Steffey E. Pharmacokinetic profile in relation to anaesthesia characteristics after a 5 % micellar microemulsion of propofol in the horse.  Br J Anaesth. 2010;  104 330-337
• 5 Filzek U, Fischer U, Ferguson J. Injektionsnarkosen beim Pferd – Ketaminrazemat versus S-(+)-Ketamin bei 20 Pferden unter Klinikbedingungen (Intravenous anaesthesia in horses: racemic ketamine versus S-(+)-ketamine).  Pferdeheilkunde. 2003;  19 501-506
• 6 Hubbell J, Hinchcliff K, Schmall L, Muir W, Robertson J, Sams R. Anesthetic, cardiorespiratory, and metabolic effects of four intravenous anesthetic regimens induced in horses immediately after maximal exercise.  Am J Vet Res. 2000;  61 1545-1552
• 7 Johnston G, Taylor P, Wood J. The confidential enquiry of perioperative equine fatalities (CEPEF-1): mortality results in phases 1 and 2.  Vet Anaesth Analg. 2002;  29 159-170
• 8 Knobloch M, Portier C, Levionnois O, Theurillat R, Thormann W, Spadavecchia C, Mevissen M. Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion.  Toxicol Appl Pharmacol. 2006;  216 373-386
• 9 Lankveld D, Bull S, Dijk P V, Fink-Gremmels J, Hellebrekers L. Ketamine inhibits LPS-induced tumour necrosis factor-alpha and interleukin-6 in an equine macrophage cell line.  Vet Res. 2005;  36 257-262
• 10 Larenza M, Ringer S, Kutter A, Conrot A, Theurillat R, Kummer M, Thormann W, Bettschart-Wolfensberger R. Evaluation of anesthesia recovery quality after low-dose racemic or S-ketamine infusions during anesthesia with isoflurane in horses.  Am J Vet Res. 2009;  70 710-718
• 11 Latzel S. Klinische und pharmakologische Untersuchungen zur Eliminationskinetik von Xylazin (Rompun) beim Maultier. [Dissertation]. LMU München; 2008
• 12 Leece E, Girard N, Maddern K. Alfaxalone in cyclodextrin for induction and maintenance of anaesthesia in ponies undergoing field castration.  Vet Anaesth Analg. 2009;  36 480-484
• 13 Levionnois O, Mevissen M, Thormann W, Spadavecchia C. Assessing the efficiency of a pharmacokinetic-based algorithm for target-controlled infusion of ketamine in ponies.  Res Vet Sci. 2010;  88 512-518
• 14 Luna S, Taylor P, Bloomfield M. Endocrine changes in cerebrospinal fluid, pituitary effluent, and peripheral plasma of anesthetized ponies.  Am J Vet Res. 1997;  58 765-770
• 15 Luna S, Taylor P, Wheeler M. Cardiorespiratory, endocrine and metabolic changes in ponies undergoing intravenous or inhalation anaesthesia.  J Vet Pharmacol Therap. 1996;  19 251-258
• 16 Mama K, Pascoe P, Steffey E, Kollias-Baker C. Comparison of two techniques for total intravenous anesthesia in horses.  Am J Vet Res. 1998;  59 1292-1298
• 17 Mama K, Wagner A, Steffey E, Kollias-Baker C, Hellyer P, Golden A, Brevard L. Evaluation of xylazine and ketamine for total intravenous anesthesia in horses.  Am J Vet Res. 2005;  66 1002-1007
• 18 Marntell S, Nyman G, Funkquist P, Hedenstierna G. Effects of acepromazine on pulmonary gas exchange and circulation during sedation and dissociative anaesthesia in horses.  Vet Anaesth Analg. 2005;  32 83-93
• 19 Matthews N, Peck K, Mealey K, Taylor T, Ray A. Pharmacokinetics and cardiopulmonary effects of guaifenesin in donkeys.  J Vet Pharmacol Therap. 1997;  20 442-446
• 20 Matthews N, Taylor T, Skrobarcek C, Williams J. A comparison of injectable anaesthetic regimens in mules.  Equine Vet J. 1992;  24 (Suppl. 11) 34-36
• 21 Muir W, Skarda R, Wilme D. Evaluation of xylazine and ketamine hydrochloride for anesthesia in horses.  Am J Vet Res. 1977;  38 195-201
• 22 Schneemilch C, Ittenson A, Ansorge S, Hachenberg T, Bank U. Effect of 2 anesthetic techniques on the postoperative proinflammatory and anti-inflammatory cytokine response and cellular immune function to minor surgery.  J Clin Anesth. 2005;  17 517-527
• 23 Taylor P, Kirby J, Shrimpton D, Johnson C. Cardiovascular effects of surgical castration during anaesthesia maintained with halothane or infusion of detomidine, ketamine and guaifenesin in ponies.  Equine Vet J. 1998;  30 304-309
• 24 Taylor P, Luna S, Sear J, Wheeler M. Total intravenous anaesthesia in ponies using detomidine, ketamine and guaiphenesin: pharmacokinetics, cardiopulmonary and endocrine effects.  Res Vet Sci. 1995;  59 17-23
• 25 Yamashita K, Wijayathilaka T, Kushiro T, Umar M, Taguchi K, Muir W. Anesthetic and cardiopulmonary effects of total intravenous anesthesia using a midazolam, ketamine and medetomidine drug combination in horses.  J Vet Med Sci. 2007;  69 7-13